Analyst firms · Citizens JMP · ANTX
Citizens JMP ANTX price target and rating history
AN2 Therapeutics Inc. (ANTX) · Health Care
Citizens JMP rates AN2 Therapeutics Inc. (ANTX) Mkt Outperform with a $6 price target, as of its latest action on Apr 2, 2024. It has published 3 rating actions on ANTX since January 2024, including 1 upgrade and 1 downgrade.
- Current rating
- Mkt Outperform
- Price target
- $6
- Median target, all firms
- Too few
- Actions on ANTX
- 3
Citizens JMP price target on ANTX
Every Citizens JMP rating on ANTX
- Apr 2, 2024
- Feb 12, 2024
- Jan 4, 2024
Questions about Citizens JMP and ANTX
- What is Citizens JMP's price target for ANTX?
- Citizens JMP's latest stated price target for AN2 Therapeutics Inc. (ANTX) is $6, from its action on Apr 2, 2024.
- What is Citizens JMP's rating on ANTX?
- Citizens JMP rates ANTX Mkt Outperform, a bullish rating, as of Apr 2, 2024.
- When did Citizens JMP last change its view on ANTX?
- On Apr 2, 2024, Citizens JMP upgrades to Mkt Outperform from Mkt Perform, price target $6.
More ANTX rating histories
All Citizens JMP ratingsANTX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.